Researchers focus on the identification of markers to improve head and neck cancer risk assessment

Malignant tumors in the head and neck region are very heterogeneous and therefore difficult to treat. In addition, the lack of prognostic markers is a significant impediment to personalized treatment.

Related Keywords

Austria ,Clemens Spielvogel ,Alexander Haug ,Siemens Healtheneers ,Lukas Kenner ,Emily Henderson ,Nuclear Medicine ,Meduni Vienna Department Of Radiology ,European Journal Of Nuclear Medicine ,Christian Doppler Laboratory For Metabolomics ,Christian Doppler Laboratory For Applied Metabolomics ,Meduni Vienna Clinical Institute Of Pathology ,Meduni Vienna ,Christian Doppler Laboratory ,Applied Metabolomics ,European Journal ,Clinical Institute ,Genomics Industry Focus ,Global Cancer Studies ,Statistics Austria ,Cancer ,Head And Neck Cancer ,Neck ,Carcinomas ,Na ,Enetic ,Maging ,Laboratory ,Alignant ,Medicine ,Metabolomics ,Molecular Imaging ,Research ,